Newer Chemotheraphy Strategies In Patients With Refractory Non-Hodgkin's Lymphoma
Article Sidebar
Main Article Content
Abstract
This report centers upon the evolution of chemotherapeutic programmes employed over the years in combination with other therapeutic modalities in the management of advanced non-Hodgkin's lymphoma which can be counted among the most chemo and radio-sensitive tumors that are encountered in clinical practice. The evolutionary sequence leading to our present concept in the therapy of non-Hodgkin's lymphoma has passed through several stages.
Article Details
Work published in JPMI is licensed under a
Creative Commons Attribution-NonCommercial 2.0 Generic License.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.